71
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hugh Sturrock and colleagues discuss the role of active case detection in low malaria transmission settings. They argue that the evidence for its effectiveness is sparse and that targeted mass drug administration should be evaluated as an alternative or addition to active case detection.

          Please see later in the article for the Editors' Summary

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT).

          The absolute necessity for rational therapy in the face of rampant drug resistance places increasing importance on the accuracy of malaria diagnosis. Giemsa microscopy and rapid diagnostic tests (RDTs) represent the two diagnostics most likely to have the largest impact on malaria control today. These two methods, each with characteristic strengths and limitations, together represent the best hope for accurate diagnosis as a key component of successful malaria control. This review addresses the quality issues with current malaria diagnostics and presents data from recent rapid diagnostic test trials. Reduction of malaria morbidity and drug resistance intensity plus the associated economic loss of these two factors require urgent scaling up of the quality of parasite-based diagnostic methods. An investment in anti-malarial drug development or malaria vaccine development should be accompanied by a parallel commitment to improve diagnostic tools and their availability to people living in malarious areas.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            A new world malaria map: Plasmodium falciparum endemicity in 2010

            Background Transmission intensity affects almost all aspects of malaria epidemiology and the impact of malaria on human populations. Maps of transmission intensity are necessary to identify populations at different levels of risk and to evaluate objectively options for disease control. To remain relevant operationally, such maps must be updated frequently. Following the first global effort to map Plasmodium falciparum malaria endemicity in 2007, this paper describes the generation of a new world map for the year 2010. This analysis is extended to provide the first global estimates of two other metrics of transmission intensity for P. falciparum that underpin contemporary questions in malaria control: the entomological inoculation rate (PfEIR) and the basic reproductive number (PfR). Methods Annual parasite incidence data for 13,449 administrative units in 43 endemic countries were sourced to define the spatial limits of P. falciparum transmission in 2010 and 22,212 P. falciparum parasite rate (PfPR) surveys were used in a model-based geostatistical (MBG) prediction to create a continuous contemporary surface of malaria endemicity within these limits. A suite of transmission models were developed that link PfPR to PfEIR and PfR and these were fitted to field data. These models were combined with the PfPR map to create new global predictions of PfEIR and PfR. All output maps included measured uncertainty. Results An estimated 1.13 and 1.44 billion people worldwide were at risk of unstable and stable P. falciparum malaria, respectively. The majority of the endemic world was predicted with a median PfEIR of less than one and a median PfR c of less than two. Values of either metric exceeding 10 were almost exclusive to Africa. The uncertainty described in both PfEIR and PfR was substantial in regions of intense transmission. Conclusions The year 2010 has a particular significance as an evaluation milestone for malaria global health policy. The maps presented here contribute to a rational basis for control and elimination decisions and can serve as a baseline assessment as the global health community looks ahead to the next series of milestones targeted at 2015.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.

              Plasmodium vivax is geographically the most widely distributed cause of malaria in people, with up to 2.5 billion people at risk and an estimated 80 million to 300 million clinical cases every year--including severe disease and death. Despite this large burden of disease, P vivax is overlooked and left in the shadow of the enormous problem caused by Plasmodium falciparum in sub-Saharan Africa. The technological advances enabling the sequencing of the P vivax genome and a recent call for worldwide malaria eradication have together placed new emphasis on the importance of addressing P vivax as a major public health problem. However, because of this parasite's biology, it is especially difficult to interrupt the transmission of P vivax, and experts agree that the available methods for preventing and treating infections with P vivax are inadequate. It is thus imperative that the development of new methods and strategies become a priority. Advancing the development of such methods needs renewed emphasis on understanding the biology, pathogenesis, and epidemiology of P vivax. This Review critically examines what is known about P vivax, focusing on identifying the crucial gaps that create obstacles to the elimination of this parasite in human populations.
                Bookmark

                Author and article information

                Journal
                PLoS Med
                PLoS Med
                PLoS
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                June 2013
                June 2013
                18 June 2013
                : 10
                : 6
                : e1001467
                Affiliations
                [1 ]Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, United States of America
                [2 ]Department of Pediatrics, University of California, San Francisco, United States of America
                [3 ]Clinton Health Access Initiative, Boston, MA, United States of America
                [4 ]Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America
                [5 ]Department of Medicine, University of California, San Francisco, United States of America
                [6 ]Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
                [7 ]Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
                Author notes

                The authors have declared that no competing interests exist.

                Wrote the first draft of the manuscript: HJWS MSH RDG. Contributed to the writing of the manuscript: HJWS MSH JMC DLS BG TB RDG. ICMJE criteria for authorship read and met: HJWS MSH JMC DLS BG TB RDG. Agree with manuscript’s results and conclusions: HJWS MSH JMC DLS BG TB RDG.

                The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving health care in their societies.

                Article
                PMEDICINE-D-12-03313
                10.1371/journal.pmed.1001467
                3708701
                23853551
                7cea42a6-638d-4be1-89de-786902490e49
                Copyright @ 2013

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                Page count
                Pages: 8
                Funding
                HJWS and RDG are supported by a grant from the Bill & Melinda Gates Foundation [#OPP1013170]. MSH is supported by a National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) K23 Award [#P0045532] and a Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship [#P0049395]. DLS acknowledges support from the Bill & Melinda Gates Foundation [#49446], the RAPIDD Program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. BG is supported by a NIH/NIAID K23 Award [#AI076614] and is a recipient of a Doris Duke Clinical Scientist Development Award. DLS and BG are also supported by an International Centers of Excellence in Malaria Research U19 [#AI089674]. TB is supported by a Grand Challenge Grant of the Bill & Melinda Gates Foundation (No. OPP1024438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Policy Forum
                Medicine
                Infectious Diseases
                Tropical Diseases (Non-Neglected)
                Malaria
                Plasmodium Falciparum
                Plasmodium Vivax
                Infectious Disease Control

                Medicine
                Medicine

                Comments

                Comment on this article